Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

David Dynnes Ørsted; Børge G Nordestgaard; Gorm B Jensen; Peter Schnohr; Stig E Bojesen

doi:10.1016/j.eururo.2011.11.007

Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

David Dynnes Ørsted
, Børge G Nordestgaard
, Gorm B Jensen
, Peter Schnohr
, Stig E Bojesen

42 Citationer (Scopus)

Abstract

It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

Originalsprog	Engelsk
Tidsskrift	European Urology (Italian Edition)
Vol/bind	61
Udgave nummer	5
Sider (fra-til)	865-74
Antal sider	10
ISSN	1828-6569
DOI	https://doi.org/10.1016/j.eururo.2011.11.007
Status	Udgivet - 2012

Adgang til dokumentet

10.1016/j.eururo.2011.11.007

Citationsformater

@article{3cbbdeeca0e848faa5154bb107fcaa84,

title = "Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population",

abstract = "It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.",

author = "{\O}rsted, \{David Dynnes\} and Nordestgaard, \{B{\o}rge G\} and Jensen, \{Gorm B\} and Peter Schnohr and Bojesen, \{Stig E\}",

year = "2012",

doi = "10.1016/j.eururo.2011.11.007",

language = "English",

volume = "61",

pages = "865--74",

journal = "European Urology (Italian Edition)",

issn = "1828-6569",

publisher = "Elsevier Masson",

number = "5",

}

TY - JOUR

T1 - Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

AU - Ørsted, David Dynnes

AU - Nordestgaard, Børge G

AU - Jensen, Gorm B

AU - Schnohr, Peter

AU - Bojesen, Stig E

PY - 2012

Y1 - 2012

N2 - It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

AB - It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

U2 - 10.1016/j.eururo.2011.11.007

DO - 10.1016/j.eururo.2011.11.007

M3 - Journal article

C2 - 22104593

SN - 1828-6569

VL - 61

SP - 865

EP - 874

JO - European Urology (Italian Edition)

JF - European Urology (Italian Edition)

IS - 5

ER -

Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater